Search all trials

Find therapies in clinical trials near you – page 6

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Dyslipidaemia+1

Recruiting

Registered drug

Study of the efficacy and safety of inclisiran and a drug combination in patients with acute coronary syndrome

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Atorvastatin

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drug

Study of Ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Autoimmune haemolytic anaemia+1

Recruiting

Registered drugNo placebo

A study to evaluate the safety and effectiveness of tafasitamab in adults with autoimmune thrombocytopenia or autoimmune hemolytic anemia

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Tafasitamab

Contact Research Centre

Plasma cell myeloma

Recruiting

Registered drugNo placebo

A study of etentamig and daratumumab compared to daratumumab, lenalidomide, and dexamethasone in adults with newly diagnosed multiple myeloma not eligible for transplant

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

A study evaluating the efficacy and safety of secukinumab compared to a drug combination in patients with severe Takayasu arteritis.

Recruiting

Registered drugNo placebo

A study evaluating the efficacy and safety of secukinumab compared to a drug combination in patients with severe Takayasu arteritis.

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Adalimumab

Contact Research Centre

Acute leukaemia

Recruiting

InvestigationalNo placebo

A study of Enzomenib in adult patients with relapsed or refractory acute leukemia, including those with MLL rearrangement or NPM1 mutation.

InvestigationalNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Metabolic dysfunction-associated liver disease

Recruiting

Investigational

N1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD

Investigational

France

Participants:18–64 years · 65+ years
Substances:Ly3437943 Sodium

Contact Research Centre

Interstitial lung disease

Recruiting

Registered drug

Efficacy and Safety of Subcutaneous Belimumab in Adults with Connective Tissue Disease-Associated Interstitial Lung Disease

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Belimumab

Contact Research Centre

Hepatitis D

Recruiting

Registered drugNo placebo

A study comparing brelovitug to bulevirtide for treating chronic hepatitis delta infection in patients currently receiving bulevirtide

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bjt-778

Contact Research Centre

Adrenogenital syndrome

Recruiting

Investigational

A Study Testing Atumelnant Compared to Placebo in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Steroid Dose While Controlling Hormones

Investigational

France

Participants:18–64 years · 65+ years
Substances:ATUMELNANT

Contact Research Centre

Cardiac amyloidosis

Recruiting

Investigational

A study of coramitug compared to placebo for people with heart failure caused by transthyretin amyloid cardiomyopathy

Investigational

France

Participants:18–64 years · 65+ years

Contact Research Centre

Alpha-1 antitrypsin deficiency

Recruiting

InvestigationalNo placebo

A study comparing under-the-skin and into-the-vein alpha1-proteinase inhibitor treatment in patients with alpha1-antitrypsin deficiency

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Human Alpha1-Proteinase Inhibitor

Contact Research Centre

Find therapies in clinical trials near you – page 6

594 trials match your criteria

Dyslipidaemia+1

Study of the efficacy and safety of inclisiran and a drug combination in patients with acute coronary syndrome

Acute myeloid leukaemia

Study of Ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes

Autoimmune haemolytic anaemia+1

A study to evaluate the safety and effectiveness of tafasitamab in adults with autoimmune thrombocytopenia or autoimmune hemolytic anemia

Plasma cell myeloma

A study of etentamig and daratumumab compared to daratumumab, lenalidomide, and dexamethasone in adults with newly diagnosed multiple myeloma not eligible for transplant

A study evaluating the efficacy and safety of secukinumab compared to a drug combination in patients with severe Takayasu arteritis.

A study evaluating the efficacy and safety of secukinumab compared to a drug combination in patients with severe Takayasu arteritis.

Acute leukaemia

A study of Enzomenib in adult patients with relapsed or refractory acute leukemia, including those with MLL rearrangement or NPM1 mutation.

Metabolic dysfunction-associated liver disease

Interstitial lung disease

Efficacy and Safety of Subcutaneous Belimumab in Adults with Connective Tissue Disease-Associated Interstitial Lung Disease

Hepatitis D

A study comparing brelovitug to bulevirtide for treating chronic hepatitis delta infection in patients currently receiving bulevirtide

Adrenogenital syndrome

A Study Testing Atumelnant Compared to Placebo in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Steroid Dose While Controlling Hormones

Cardiac amyloidosis

A study of coramitug compared to placebo for people with heart failure caused by transthyretin amyloid cardiomyopathy

Alpha-1 antitrypsin deficiency

A study comparing under-the-skin and into-the-vein alpha1-proteinase inhibitor treatment in patients with alpha1-antitrypsin deficiency

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.